BLUEBERRY: Effect of Bilberry (European Blueberries) and Grape Polyphenols on Cognition and Blood Parameters

Sponsor
Ullevaal University Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT00972972
Collaborator
University of Oslo (Other)
61
1
2
36
1.7

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether dietary intervention with blueberry and grape juice extracts in elderly men with subjective memory problems would raise performance on neuropsychological memory tests and change biomarker of muscle damage and whole blood gene expression profiles.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: bilberry (European blueberries) and red grape juice
  • Dietary Supplement: placebo juice
Early Phase 1

Detailed Description

A number of studies have shown that increased dietary intake of fruits and vegetable extracts high in antioxidants (e.g., blueberries, strawberries and spinach) can retard and even reverse age-related decline in brain function and in cognitive and motor performance in rats. This is the first placebo-controlled human study to evaluate the effect of dietary intake of fruit polyphenols on neuropsychological test scores and whole blood gene regulation

Sixty-two non-demented, non-depressed men (age 67-77 years) with subjective memory decline, were randomly assigned to a blueberry/grape juice- and placebo-group in a 9 week double blind intervention study. Pre- and post treatment assessment were measured with a computerised neuropsychological test battery (CANTAB), including tests for motor speed, visual reaction time, and spatial memory. Dietary habits were registered before intervention and several clinical biomarkers were measured in plasma/serum before and after the intervention. Pre- and post intervention-samples for measurement of gene regulation were also collected

Study Design

Study Type:
Interventional
Actual Enrollment :
61 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
Effect of Bilberry (European Blueberries) and Grape Polyphenols on Cognition and Blood Parameters in Normal, Aged Men With Subjective Memory Decline
Study Start Date :
Dec 1, 2006
Anticipated Primary Completion Date :
Jul 1, 2007
Anticipated Study Completion Date :
Dec 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: dietary supplement

Extracts of bilberry (European blueberries) and red grape juice (Merlot grapes; Vitis Vinifera L.)

Dietary Supplement: bilberry (European blueberries) and red grape juice
Intervention juice: 50/50 combination of 300 ml bilberry (European blueberries) and red grape juice (Merlot grapes; Vitis Vinifera L.) per day for 9 weeks
Other Names:
  • Bilberry
  • European blueberries
  • polyphenols
  • Placebo Comparator: placebo dietary supplement

    Placebo juice extracts

    Dietary Supplement: placebo juice
    Placebo juice: 300 ml, similar to the intervention juice as to taste, energy, salt, and carbohydrates

    Outcome Measures

    Primary Outcome Measures

    1. neuropsychological test scores and whole blood gene regulation [December 2006 - july 2007]

    2. whole blood gene regulation; parameters in blood [2006 and 2007]

    3. neuropsychological test scores; whole blood gene regulation; parameters in blood [2006 and 2007]

    Secondary Outcome Measures

    1. gene expression of stress, repair and maintenance processes measured by whole genome microarray analysis in blood [2007 and 2009]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    67 Years to 77 Years
    Sexes Eligible for Study:
    Male
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • men

    • age 67-77 years

    • gradual subjective memory decline

    • response to advertisement

    Exclusion Criteria:
    • head trauma with loss of consciousness and lasting symptoms

    • brain stroke within last 3 years

    • dementia, clinically diagnosed

    • signs of brain-degenerative disease

    • Mini Mental Status Examination score less than 26

    • depression (MADRS; Montgomery Asberg Depression Rating Scale score above 20)

    • ongoing treatment for cancer (cytostatica)/diabetes

    • reported or observed serious mental illness

    • reported or observed use of narcotics (any, present or past)

    • reported or observed abuse of alcohol

    • visual, auditory, or motor handicaps of relevance for performance

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ulleval University Hospital HF Oslo Norway 0407

    Sponsors and Collaborators

    • Ullevaal University Hospital
    • University of Oslo

    Investigators

    • Principal Investigator: KJELL - FLEKKOY, DR. PHILOS., ULLEVAAL UNIVERSITY HOSPITAL; UNIVERSITY OF OSLO
    • Principal Investigator: RUNE - BLOMHOFF, DR. MED., University of Oslo

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00972972
    Other Study ID Numbers:
    • 699
    First Posted:
    Sep 9, 2009
    Last Update Posted:
    Sep 15, 2009
    Last Verified:
    Sep 1, 2009

    Study Results

    No Results Posted as of Sep 15, 2009